Sign up for our daily briefing

Make your busy days simpler with Axios AM/PM. Catch up on what's new and why it matters in just 5 minutes.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Stay on top of the latest market trends

Subscribe to Axios Markets for the latest market trends and economic insights. Sign up for free.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Sports news worthy of your time

Binge on the stats and stories that drive the sports world with Axios Sports. Sign up for free.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Tech news worthy of your time

Get our smart take on technology from the Valley and D.C. with Axios Login. Sign up for free.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Get the inside stories

Get an insider's guide to the new White House with Axios Sneak Peek. Sign up for free.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Catch up on coronavirus stories and special reports, curated by Mike Allen everyday

Catch up on coronavirus stories and special reports, curated by Mike Allen everyday

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Denver news?

Get a daily digest of the most important stories affecting your hometown with Axios Denver

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Des Moines news?

Get a daily digest of the most important stories affecting your hometown with Axios Des Moines

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Twin Cities news?

Get a daily digest of the most important stories affecting your hometown with Axios Twin Cities

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Tampa Bay news?

Get a daily digest of the most important stories affecting your hometown with Axios Tampa Bay

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Charlotte news?

Get a daily digest of the most important stories affecting your hometown with Axios Charlotte

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Illustration: Aïda Amer/Axios

President Trump has threatened and bludgeoned his way into an unwanted confrontation with the U.S. business community that could have far-reaching implications for the future of presidential power over trade.

Driving the news: Trump's blunt use of presidential leverage to force the Mexican government to harden its immigration enforcement appears to have caused an unintended side effect: U.S. business leaders have begun urgently discussing strategies to claw back the virtually unchecked trade powers that Congress has handed over to presidents during the past 80 years.

The big picture: Even though the business community is now breathing a sigh of relief that Trump won't be hitting Mexico with new tariffs, the last week of Trump's threats may have a longer lasting effect, according to industry sources who have met with corporate representatives in Washington, leaders of business associations, administration officials, members of Congress and their senior staff.

  • Trump's threat to impose rising tariffs on all Mexican goods to punish the Mexican government for soft immigration enforcement sparked a widespread panic in the U.S. business community and turned their conversations in an unprecedented direction, these sources said.
  • John Murphy, who runs international policy at the Chamber of Commerce, tweeted, "In the space of a few hours ... more than 140 business and agricultural associations signed this statement opposing tariffs on goods from Mexico."
  • "Maybe folks in the White House don't know this, but they freaked out a lot of people," a trade lawyer involved in these conversations told me.

"This is a real turning point because this is threatening tariffs using an emergency power," said another top industry source involved. "That's never been done before. Part of the resources that we want to direct our advocacy to ... is for Congress to take back authority over tariffs."

  • "We can get back on USMCA and try to pass the thing and we can all be hunky-dory, but I think you're going to see a longer term business community effort to help Congress reassert its authority on tariffs."
  • Legislation could go so far as requiring congressional approval of most presidential trade actions. (We're already seeing some efforts along these lines, led by Republican Sens. Chuck Grassley and Pat Toomey.)

Behind the scenes: Before Trump called off his tariffs on Friday night, a loose coalition of organizations supporting Trump's renegotiated NAFTA, the United States–Mexico–Canada Agreement, were discussing halting a multimillion-dollar campaign to support the passage of USMCA.

  • Instead, these business lobby groups and leaders of large corporations were discussing redirecting their money toward opposing Trump's tariffs and potentially to support efforts to claw back the president's trade powers, according to sources familiar with their internal discussions.
  • They will now return to funding a USMCA campaign, but the past week has shown them that they need to finally get serious about stopping this president — and future presidents — from unilaterally raising tariffs.

Why it matters: Trump can only credibly threaten foreign countries with abrupt tariffs because Congress has gradually given away its trade powers. Opponents of this trend say it's unconstitutional because taxing and commerce authority lies with Congress (as expressed in Article 1 of the Constitution).

  • Until fairly recently, only a wonky fringe in Washington cared about this issue. Few paid attention when Republican Sen. Mike Lee introduced legislation in early 2017 to "subject all executive branch trade actions (including raising tariffs) to congressional approval."

The bottom line: Over the past week, these previously fringy conversations entered the mainstream. Watch for a long-term, well-funded campaign to peel trade powers away from the president.

Go deeper

House passes $1.9 trillion COVID relief package

Photo: Screenshot via C-SPAN

The House approved President Biden's $1.9 trillion COVID relief package on a 219-212 vote early Saturday morning, sending it to the Senate for a possible rewrite before it gets to Biden's desk.

The big picture: The vote was a critical first step for the package, which includes $1,400 cash payments for many Americans, a national vaccination program, ramped-up COVID testing and contact tracing, state and local funding and money to help schools reopen.

10 hours ago - Health

Biden says it's "not the time to relax" after touring vaccination site

President Biden speaking after visiting a FEMA Covid-19 vaccination facility in Houston on Feb. 26. Photo: Mandel Ngan/AFP via Getty Images

President Biden said Friday that "it's not the time to relax" coronavirus mitigation efforts and warned that the number of cases and hospitalizations could rise again as new variants of the virus emerge.

Why it matters: Biden, who made the remarks after touring a vaccination site in Houston, echoed CDC director Rochelle Walensky, who said earlier on Friday that while the U.S. has seen a recent drop in cases and hospitalizations, "these declines follow the highest peak we have experienced in the pandemic."

Updated 11 hours ago - Politics & Policy

Coronavirus dashboard

Illustration: Annelise Capossela/Axios

  1. Health: Most COVID-19 survivors can weather risk of reinfection, study says — "Twindemic" averted as flu reports plummet amid coronavirus crisis
  2. Vaccine: FDA advisory panel endorses J&J COVID vaccine for emergency use — About 20% of U.S. adults have received first vaccine dose, White House says — New data reignites the debate over coronavirus vaccine strategy.
  3. Economy: What's really going on with the labor market.
  4. Local: All adult Minnesotans will likely be eligible for COVID-19 vaccine by summer — Another wealthy Florida community receives special access to COVID-19 vaccine.
  5. Sports: Poll weighs impact of athlete vaccination.